期刊文献+

复方甘草甜素联合地氯雷他定治疗慢性荨麻疹疗效观察 被引量:1

Curative Effect Observation of Compound Glycyrrhizin Combined with Desloratadine in Treating Chronic Urticaria
下载PDF
导出
摘要 目的观察复方甘草甜素片联合地氯雷他定治疗慢性荨麻疹的临床疗效。方法选择本院门诊慢性荨麻疹患者,随机分为治疗组37例,对照组33例,治疗组口服复方甘草甜素片50mg,3次/日,地氯雷他定5mg,1次/日,对照组仅口服地氯雷他定,疗程均为4周。结果治疗组有效率83.78%,对照组57.58%,两种有效率比较有显著性差异(P<0.001)。结论复方甘草甜素片联合地氯雷他定治疗慢性荨麻疹的疗效确切。 Objective To observe the clinical curative effect of compound glycyrrhizin combined with dasloratadine in treating chronic urticaria. Methodss 70 cases with chronic urticaria were randomly divided into 2 groups: treatment group ( n = 37) and control group ( n = 33 ) ; patients in treatment group were given oral administration of compound glyeyrrhizin pills (50rag once and 3 times a day) and desioratadine (5mg once and once a day ) while those in control group had only desloratadine; the course lasted for 4 weeks in both groups. Results the effective rate in treatment group was 83.78 % while that in control group was 57.58 % ,the two rates were of significant difference ( P 〈 0. 001 ). Conclusions Compound glycyrrhizin combined with desloratadine is effective in treating chronic urliearia.
出处 《西南军医》 2008年第6期25-26,共2页 Journal of Military Surgeon in Southwest China
关键词 复方甘草甜素片 地氯雷他定 慢性荨麻疹 compound glycyrrhizin desloratadin chronic urticaria
  • 相关文献

参考文献2

二级参考文献8

  • 1[1]Kay GG, Harris AG. Loratadine: a non-sedating antihistamine. Review of its effects on cognition, psychomotor performance, mood and sedation[J]. Clin Exp Allergy, 1999, 29(Suppl 3): 147-150.
  • 2[2]Simons FE, McMillan JL, Simons KJ. A double-blind, singledose, crossover comparison of cetirizine, terfenadine, loratadine,astemizole, and chlorpheniramine versus placebo: Suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects[J]. J Allergy Clin Immunol, 1990, 86(4 Pt 1):540-547.
  • 3Greaves M. Chronic urticaria[J]. J Allergy Clin Immunol, 2000,105(4): 664-672.
  • 4Finlay AY, Khan GK.Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use [J]. Clin Exp Dermatol, 1994, 19(3): 210-216.
  • 5McClellan K, Jarvis B. Desloratacline[J]. Drugs, 2001, 61(6):789-796.
  • 6Geha RS, Meltzer EO. Desloratadine: A new, nonsedating, oral antihistamine[J].J Allergy Clin Immunol, 2001, 107(4): 751-762.
  • 7Ring J, Hein R,Gauger A, et al. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria:a randomized, double-blind, placebo-controlled study[J].Int J Dermatol, 2001, 40(1): 72-76.
  • 8Monroe E, Finn A, Patel P, et al. Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial[J]. J Am Acad Dermatol, 2003, 48(4): 535-541.

共引文献131

同被引文献8

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部